Logotype for Arlo Technologies Inc

Arlo Technologies (ARLO) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Arlo Technologies Inc

Q2 2026 earnings summary

6 Aug, 2026

Executive summary

  • Achieved record Q2 2026 revenue of $156 million, up 21% year-over-year, with service revenue at $93 million, and adjusted EBITDA of $31 million, both exceeding guidance.

  • Cumulative paid accounts grew 23% year-over-year to 6.3 million, with ARR up 16% to $365 million.

  • Non-GAAP EPS was $0.28, including a $0.07 benefit from an $8 million tariff refund; GAAP EPS was $0.03.

  • Net income for Q2 was $3.0 million, with non-GAAP net income at $31.1 million.

  • Two acquisitions (Canary Connect and Aloe Care Health) expanded AI-driven smart home and health services.

Financial highlights

  • Subscriptions and services revenue reached $93 million, up 19% year-over-year, representing 60% of total revenue.

  • Product revenue was $62.9 million, up 23% year-over-year, driven by international growth and retail channel strength.

  • GAAP gross margin was 48.2%, non-GAAP gross margin 50.6%, both up year-over-year, aided by $8 million in tariff refunds.

  • Free cash flow for the first half was $33.9 million (11% margin); cash and equivalents at quarter-end were $141 million.

  • Adjusted EBITDA margin reached 20%.

Outlook and guidance

  • Q3 2026 revenue expected between $140–$150 million; non-GAAP EPS forecasted at $0.17–$0.23.

  • Full-year 2026 revenue guidance raised to $580–$600 million, with non-GAAP EPS of $0.90–$1.00.

  • ARR growth targeted at 20% for the year, supported by new product launches and higher-tier subscription offerings.

  • Guidance includes expected tariff refund, to be reinvested in growth initiatives.

  • Existing liquidity expected to be sufficient for at least the next 12 months.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more